GlobeNewswire

SolarWinds System Management Updates Sharpen Visibility into Physical and Virtual Infrastructure

Dela

Support added for leading all-flash arrays from Dell EMC, HPE Nimble Storage, INFINIDAT and IBM

New functionality creates clear view of server interactions within business applications

AUSTIN, Texas, March 14, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today announced a pair of product updates that offer broader and deeper performance monitoring capabilities across physical and virtual infrastructures, particularly in hybrid environments. The newest version of SolarWinds®  Storage Resource Monitor (SRM) extends support to a wider range of leading all-flash arrays (AFAs), while the latest update to Server & Application Monitor (SAM) permits deeper visibility into interactions between a set of servers running critical business applications.

"Finding clarity through the haze of complexity is vital to successfully keep today's heterogeneous and distributed IT environments running smoothly," said Christoph Pfister, executive vice president of products, SolarWinds. "With support for more leading-edge storage vendor solutions and deeper visibility into the connection between critical infrastructure resources, our system management updates give IT professionals more powerful tools to overcome complexity and optimize performance in their diverse worlds."

Combined, the two updates arm IT professionals with the broad system management, monitoring, alerting, and reporting functionality needed to optimize performance in hybrid environments, across an even broader mix of systems and vendors.

"The latest versions of SRM and SAM are giving us even more flexibility to deploy new technologies, as well as deeper visibility across our servers and applications," said Jeremy Mayfield, IT director, American Cement Company, a leading cement producer based in Sumterville, Fla. "In particular, the new SRM support for all-flash storage, particularly HPE Nimble, will give us a wider set of options for deploying hyper-converged infrastructure.  The new application dependency capabilities in SAM allow us to see more performance data, enabling us to fix issues more quickly and reduce mean time to repair."

All-Flash Array Support for Mid-Market and Enterprise Customers with Storage Resource Monitor (SRM) 6.6

Built on the SolarWinds Orion® Platform , the latest version of SolarWinds SRM (version 6.6) now supports HPE® Nimble Storage®, Dell® EMC® Unity, INFINIDAT® InfiniBox®, and IBM® AIX® FlashSystem 9000 all-flash arrays (AFAs). With this extended support, SRM 6.6 enables resource monitoring across an even wider mix of infrastructures in multi-vendor environments to meet the needs of an even broader set of customers, particularly mid-sized companies that adopt solutions from HPE Nimble Storage, Dell EMC Unity, INFINIDAT, and IBM. 

SRM's data integration with other SolarWinds products, including Virtualization Manager (VMAN) and Server & Application Monitor (SAM) through the Orion Platform, allows for end-to-end relationship mapping from application and virtualization through storage.

Visualize Critical Application Dependencies with Server & Application Monitor (SAM) 6.6

SolarWinds SAM 6.6 offers end-to-end visibility and performance monitoring of server and applications across multiple data centers, remote locations, or the cloud. This latest update includes application dependency functionality that enables customers to automatically discover network-based relationships, between applications and servers, by correlating communications at the application process level.

IT professionals can leverage the new connection details function, a unique capability to visualize server and network metrics of specific application connections within an environment. This function gives users a fast way to visualize data on metrics such as packet loss, latency, network status, and more, thereby creating the opportunity to reduce time required for identification of root causes of application issues. With the latest enhancements, for example, a customer running a large CRM implementation can explore the dependency between its underlying database servers and associated web servers to pinpoint any performance degradation, or other issues, more efficiently.

SAM 6.6 also features a new SolarWinds Orion Agent for IBM AIX, bringing the company's powerful and affordable monitoring features to customers with IBM AIX-powered systems in their infrastructures.

Pricing and Availability

SolarWinds SRM pricing starts at $2,935* for 25 disks, including the first year of maintenance. SolarWinds SAM pricing starts at $2,995* for 150 monitors, including the first year of maintenance.

For more information, including a downloadable, free 30-day evaluation of SRM or SAM, visit the SolarWinds website , or call 866.530.8100.

*Prices as of March 14, 2018 in US Dollars. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Storage Resource Monitor
Server & Application Monitor

Connect with SolarWinds

About SolarWinds 
SolarWinds provides powerful and affordable IT management software to customers worldwide from Fortune 500® enterprises to small businesses, government agencies and educational institutions. We are committed to focusing exclusively on IT Pros, and strive to eliminate the complexity that they have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address all key areas of the infrastructure from on premises to the Cloud. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com .

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks  are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks) of their respective companies.

© 2018 SolarWinds Worldwide, LLC.  All rights reserved.

MEDIA CONTACTS:
Nicole Fachet                                                                                          
Text100                                                                                                   
Phone: 212.871.3950                                                                              
NicoleF@text100.com                                                                           

Mark Stanton
SolarWinds
Phone: 512.682.9692
pr@solarwinds.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6c5d65ff-4cd6-4cb2-9259-142a824df601




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum